HEALTHKART
-
ChrysCap set to take a bite of nutraceuticals co HealthKart
Sources told ET that the existing investor Peak XV (formerly Sequoia) will sell their stake in this round. In its latest round, HealthKart had raised $135 million (about ₹1,100 crore), led by Singapore's sovereign fund Temasek at a valuation of $370 million in 2022.
-
HealthKart raises $135 million funding led by Temasek
-
Preventive healthcare concern has made Indians shift from reactive to proactive measures: Sameer Maheshwari, HealthKart
-
HealthKart raises USD 25 mn from Sofina
-
Why government's new draft rule could make or break e-pharmacies like NetMeds, PharmEasy
-
Medlife has $30 million prescription to scale up business
-
Healthkart chooses nutrition & fitness over drug sales
-
Online pharmacy marketplace Netmeds.com secures Rs 324 crore in funding
Join the community of 2M+ industry professionals
Subscribe to our Daily Newsletter
Advertisement
Advertisement
Get updates on your preferred social platform
Follow us for the latest news, insider access to events and more.
